<?xml version="1.0" encoding="UTF-8"?>
<rootTag>
<Award>
<AwardTitle>GOALI:    Characterization of Dense Colloidal Suspensions With Frequency-Domain Photon Migration (FDPM)</AwardTitle>
<AwardEffectiveDate>12/01/2004</AwardEffectiveDate>
<AwardExpirationDate>08/31/2006</AwardExpirationDate>
<AwardAmount>88774</AwardAmount>
<AwardInstrument>
<Value>Continuing grant</Value>
</AwardInstrument>
<Organization>
<Code>07020000</Code>
<Directorate>
<LongName>Directorate For Engineering</LongName>
</Directorate>
<Division>
<LongName>Div Of Chem, Bioeng, Env, &amp; Transp Sys</LongName>
</Division>
</Organization>
<ProgramOfficer>
<SignBlockName>Keith E. Herold</SignBlockName>
</ProgramOfficer>
<AbstractNarration>ABSTRACT&lt;br/&gt;&lt;br/&gt;Proposal Number: CTS-0213280&lt;br/&gt;Principal Investigator: Sevick-Muraca, Eva M&lt;br/&gt;Affiliation: Texas Engineering Exp Sta&lt;br/&gt;Title: GOALI - Characterization of Dense Colloidal Suspensions with FDPM&lt;br/&gt;&lt;br/&gt;In this project, the PI proposes to (i) develop and test new inverse algorithms for assessing particle size and size distribution in monodisperse, binary, and polydisperse suspensions from experimental multi-wavelength FDPM data, (ii) assess changes in FDPM measured scattering properties arising from depletion force, electrostatic interactions, and colloids functionalized with ligand receptor systems of biological significance; and (iii) evaluate those changes in the context of first principles models of partial structure factor.  The final objective of the GOALI project is to develop a low cost, simple diagnostics tool in characterize the interaction between colloidal particles in dense suspensions.  Extension of the system to on-line characterization of intermediate and final colloidal products is planned for chemical, pharmaceutical, and biotechnology industries.&lt;br/&gt;</AbstractNarration>
<MinAmdLetterDate>03/16/2005</MinAmdLetterDate>
<MaxAmdLetterDate>07/27/2005</MaxAmdLetterDate>
<ARRAAmount/>
<AwardID>0511915</AwardID>
<Investigator>
<FirstName>Emile</FirstName>
<LastName>Schweikert</LastName>
<EmailAddress>schweikert@chem.tamu.edu</EmailAddress>
<StartDate>07/27/2005</StartDate>
<EndDate/>
<RoleCode>Principal Investigator</RoleCode>
</Investigator>
<Investigator>
<FirstName>Eva</FirstName>
<LastName>Sevick-Muraca</LastName>
<EmailAddress>eva-m-sevick@tamu.edu</EmailAddress>
<StartDate>03/16/2005</StartDate>
<EndDate>07/27/2005</EndDate>
<RoleCode>Former Principal Investigator</RoleCode>
</Investigator>
<Institution>
<Name>Texas A&amp;M Research Foundation</Name>
<CityName>College Station</CityName>
<ZipCode>778454375</ZipCode>
<PhoneNumber>9798626777</PhoneNumber>
<StreetAddress>400 Harvey Mitchell Parkway, S</StreetAddress>
<CountryName>United States</CountryName>
<StateName>Texas</StateName>
<StateCode>TX</StateCode>
</Institution>
<ProgramElement>
<Code>1415</Code>
<Text>PARTICULATE &amp;MULTIPHASE PROCES</Text>
</ProgramElement>
<ProgramReference>
<Code>0000</Code>
<Text>UNASSIGNED</Text>
</ProgramReference>
<ProgramReference>
<Code>1504</Code>
<Text>GRANT OPP FOR ACAD LIA W/INDUS</Text>
</ProgramReference>
<ProgramReference>
<Code>OTHR</Code>
<Text>OTHER RESEARCH OR EDUCATION</Text>
</ProgramReference>
</Award>
</rootTag>
